Ketamine: Mechanisms and Relevance to Treatment of Depression.

Kim, Ji-Woon; Suzuki, Kanzo; Kavalali, Ege T; Monteggia, Lisa M

Kim, Ji-Woon; Suzuki, Kanzo; Kavalali, Ege T; Monteggia, Lisa M.

Afiliación

Kim JW; Department of Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee, USA; email: lisa.monteggia@vanderbilt.edu.
Suzuki K; College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
Kavalali ET; Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
Monteggia LM; Institute of Regulatory Innovation through Science, Kyung Hee University, Seoul, Republic of Korea.

Annu Rev Med ; 75: 129-143, 2024 Jan 29.

Article en En | MEDLINE | ID: mdl-37729028

Asunto(s)

Trastorno Depresivo Mayor; Ketamina; Humanos; Ketamina/uso terapéutico; Depresión/tratamiento farmacológico; Trastorno Depresivo Mayor/tratamiento farmacológico; Antidepresivos/uso terapéutico; Aminas/uso terapéutico

Palabras clave

NMDA receptor; antidepressant; hippocampus; ketamine; major depressive disorder; synaptic plasticity; treatment-resistant depression

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor / Ketamina Límite: Humans Idioma: En Revista: Annu Rev Med Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google